Analytical briefings for engineers, PMs, and CTOs
6 min readDocument AI and audio transcription are in production at scale. Video understanding and open-ended visual reasoning are still in pilot. A modality-by-modality breakdown of where multimodal AI has earned its place in enterprise workflows — and where reliability gaps are keeping CFOs from removing human review.
6 min readSK Hynix controls 62% of global HBM shipments and sold out its entire 2026 production by mid-2025. Here is why High Bandwidth Memory — not TSMC node capacity or CoWoS packaging — has become the single binding constraint on the AI infrastructure build-out, and what Samsung’s 18-month qualification failure reveals about the difficulty of meeting NVIDIA’s thermal and power standards.
7 min readA documented sequence of confirmed attacks across 2025 — including zero-click data exfiltration via Microsoft 365 Copilot and malicious MCP servers distributed through npm — defines a new category of enterprise exposure. Here is what the incident record shows and what security teams must do now.
4 min readControlled studies show AI coding assistants reduce time-to-completion by 26–55% — but gains concentrate in code generation and do not extend uniformly to debugging, architecture, or code review. The contexts matter enormously.
3 min readIntel’s Hala Point and IBM’s NorthPole deliver 22–100x energy efficiency gains over GPUs on specific sparse workloads — but no standard programming model, a thin software ecosystem, and narrow task compatibility have kept neuromorphic chips out of commercial AI deployments.
3 min readMicrosoft, Google, Amazon, and Meta will collectively spend over $320 billion on AI infrastructure in 2026 — but more than 60% is going into power infrastructure and data centre construction, not compute hardware. The binding constraint has shifted from chips to electricity.
4 min readOver 150 AI-designed drug candidates are in clinical trials globally — a 7x increase since 2022. AlphaFold 3 has compressed pre-clinical discovery from 4–6 years to 12–24 months. The first FDA approvals of AI-primary drug candidates are 3–5 years away.
4 min readEnterprise AI ROI is real but concentrated: financial services, healthcare administration, and software development show payback periods under 18 months. Forty-one percent of enterprise deployments remain in pilot phase after more than 12 months.
4 min readThe US has no federal AI law, 40+ competing state bills, and executive orders that reversed within two years. For enterprises deploying AI in hiring, credit, and healthcare, legal exposure exists now under existing anti-discrimination and consumer protection law — not future AI-specific regulation.
4 min read2025 will be remembered not for the volume of AI announcements but for five shifts that had real structural weight. Models got smarter, cheaper, and started taking action — but the more important story was what each shift revealed about where the field was actually heading.